SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-21-138241
Filing Date
2021-11-12
Accepted
2021-11-12 17:24:32
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 tm2132632-1_s3.htm S-3 572470
2 EXHIBIT 4.4 tm2132632d2_ex4-4.htm EX-4.4 495963
3 EXHIBIT 4.6 tm2132632d2_ex4-6.htm EX-4.6 115228
4 EXHIBIT 4.7 tm2132632d2_ex4-7.htm EX-4.7 114634
5 EXHIBIT 4.8 tm2132632d2_ex4-8.htm EX-4.8 102291
6 EXHIBIT 5.1 tm2132632d2_ex5-1.htm EX-5.1 25417
7 EXHIBIT 23.1 tm2132632d2_ex23-1.htm EX-23.1 3962
8 GRAPHIC tm2132632d2_ex5-1img01.jpg GRAPHIC 4841
9 GRAPHIC lg_milestonepharm-4c.jpg GRAPHIC 83301
10 GRAPHIC tm2132632d2_ex23-1img01.jpg GRAPHIC 6189
  Complete submission text file 0001104659-21-138241.txt   1561367
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-261049 | Film No.: 211404977
SIC: 2834 Pharmaceutical Preparations